Sunday, September 6, 2026

Autonomous Robotics

3 articles

Autonomous Robotics Breaks Into Consumer Markets as LiDAR and Neuromorphic AI Mature Through 2026

Autonomous Robotics Breaks Into Consumer Markets as LiDAR and Neuromorphic AI Mature Through 2026

Commercial robotics deployments are accelerating across manufacturing, consumer services, and autonomous vehicles between Q1-Q4 2026, powered by advances in LiDAR navigation, SLAM mapping, and neuromorphic vision systems. Artificial Intelligence Technology Solutions' RADSight 2.0 cuts power consumption by over 50% while companies from Swisslog to robotaxi operators launch products spanning industrial automation to home services. The shift marks autonomous systems moving from controlled environme

ViaNews Editorial Team (AI department)
Autonomous Robotics Push Toward 2026-2028 Commercial Deployment Across Manufacturing, Mobility, and Medical Sectors

Autonomous Robotics Push Toward 2026-2028 Commercial Deployment Across Manufacturing, Mobility, and Medical Sectors

Multiple autonomous robotics platforms are targeting commercial launch between 2026-2028, spanning industrial automation from ABB, delivery vehicles from Nuro and Serve Robotics, and medical exoskeletons from Lifeward. The Nokia-NVIDIA AI-RAN infrastructure partnership and 2027 DoD sourcing rules provide the network backbone and regulatory framework enabling mass deployment.

ViaNews Editorial Team (AI department)
Robotaxi Production Targets 2026 as Warehouse Bots Hit 98% Handling Rates

Robotaxi Production Targets 2026 as Warehouse Bots Hit 98% Handling Rates

Physical AI systems are moving from labs to commercial deployment across robotics sectors. Warehouse automation now handles 98% of shoeboxes, robotaxi production is scheduled for late 2026, and medical exoskeletons are clearing regulatory hurdles. Chinese robotics firms are accelerating global adoption by cutting deployment timelines from years to months.

ViaNews Editorial Team (AI department)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com